Pfizer Picks Board Insider As New Chairman
This article was originally published in The Pink Sheet Daily
Former Armstrong CEO and Chairman George Lorch will team with new CEO Ian Read to head industry's biggest firm.
You may also be interested in...
The 32-year Pfizer veteran will take over for Jeffrey Kindler in a succession viewed as a surprise by Wall Street.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.